| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 5,087,000 | 5,415,000 | 6,696,000 | 6,568,000 | | Cost of Revenue | 3,250,000 | 3,419,000 | 4,222,000 | 4,155,000 | | | Gross Profit | 1,837,000 | 1,996,000 | 2,474,000 | 2,413,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,212,000 | 1,265,000 | 1,324,000 | 1,421,000 | | Non Recurring | 4,000 | (4,000) | 28,000 |
-
| | Others | 24,000 | 23,000 | 81,000 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 597,000 | 712,000 | 1,041,000 | 992,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (11,000) | 11,000 | 35,000 | (5,000) | | Earnings Before Interest And Taxes | 586,000 | 723,000 | 1,076,000 | 987,000 | | Interest Expense | 39,000 | 54,000 | 76,000 | 41,000 | | Income Before Tax | 547,000 | 669,000 | 1,000,000 | 946,000 | | Income Tax Expense | 174,000 | 211,000 | 310,000 | 299,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 373,000 | 458,000 | 690,000 | 647,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (2,000) | (35,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 373,000 | 458,000 | 688,000 | 612,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $373,000 | $458,000 | $688,000 | $612,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
